Professor Matthew Wood
FMedSci
Professor of Neuroscience and Deputy Head of the Medical Sciences Division, University of Oxford
Chair of Management Board, academic and entrepreneur
Professor Matthew Wood specialises in RNA-based therapeutics for neuromuscular diseases. His work has advanced the development of next-generation antisense oligonucleotides for Duchenne muscular dystrophy and related conditions.
He also works to create novel drug delivery systems, including peptide and exosome-based technologies, designed for the targeted transport of biologics to critical tissues such as the brain.
As a co-founder of successful biotech spin-outs, including Evox Therapeutics and PepGen, Professor Wood has demonstrated a solid ability to translate groundbreaking research into practical therapeutic solutions. His leadership roles within research funding bodies further highlight his influence in the field of biomedical science.